MONDAY, Dec. 16, 2024 (HealthDay News) — Men who opt for “watchful waiting” instead of treatment for a low-risk prostate cancer might improve their odds if they take fish oil supplements, early research suggests. “Many men are interested in lifestyle changes, including diet, to help manage their cancer and preventContinue Reading

MONDAY, Dec. 16, 2024 (HealthDay News) — Folks with difficulty breathing can learn if they have COPD from a new AI-guided lung test, a new study suggests. The newly developed AI can accurately diagnose COPD using data from a single chest CT scan performed as a person inhales, researchers reportedContinue Reading

MONDAY, Dec. 16, 2024 (HealthDay News) — The established hormone therapy drug tamoxifen can significantly decrease the risk of cancer recurring in women with an early, low-risk form of breast cancer, a new study says. Women who took tamoxifen after undergoing a lumpectomy to remove ductal carcinoma in situ (DCIS)Continue Reading

FRIDAY, Dec. 13, 2024 (HealthDay News) — An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast cancer, a new clinical trial shows. The drug, imlunestrant, improved progression-free survival in patients whose breast cancer was driven by the female hormone estrogen. TheContinue Reading

FRIDAY, Dec. 13, 2024 (HealthDay News) — A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer. According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal carcinoma in situ (DCIS) resulted in breast cancer recurrenceContinue Reading